Filing Details
- Accession Number:
- 0001193805-13-002337
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-27 19:59:37
- Reporting Period:
- 2013-08-15
- Filing Date:
- 2013-12-27
- Accepted Time:
- 2013-12-27 19:59:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438533 | Retrophin Inc. | RTRX | Pharmaceutical Preparations (2834) | 262383102 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221599 | Steve Aselage | C/O Retrophin 777 Third Avenue, 22Nd Floor New York NY 10017 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-15 | 556 | $4.50 | 261,756 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Purchase Warrants | Acquisiton | 2013-08-15 | 278 | $0.00 | 278 | $6.00 |
| Common Stock, Par Value $0.0001 Per Share | Stock Option (Right to Buy) | Acquisiton | 2013-12-06 | 12,000 | $0.00 | 12,000 | $8.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 278 | 2013-08-15 | 2018-08-15 | No | 4 | P | Direct |
| 12,000 | 2013-12-06 | 2023-12-06 | No | 4 | A | Direct |
Footnotes
- On August 15, 2013, in connection with a private placement of the Issuer's securities, the Reporting Person acquired 556 shares of the Issuer's common stock, par value $0.0001 per share, at a purchase price of $4.50 per share, and Common Stock Purchase Warrants to purchase up to an aggregate of 278 shares of common stock. The aggregate purchase price paid by the Reporting Person in the transaction was $2,502.
Billionaire Hedge Funds
